What Caught Our Attention in the Investment World? – Week of March 6-10, 2023

By Kuldip K. Ambastha During the past trading week, the stock of Silvergate Capital Corporation (SI), a banking platform focused on the cryptocurrency industry, saw five straight days of negative returns – the largest of which was a sharp -42.2% decline on Thursday, March 9, 2023. Since 2022, Silvergate has been faced with clients withdrawing …

What Caught Our Attention in the Investment World? – Week of September 26-30, 2022

By Kuldip K. Ambastha On Thursday, September 29, 2022, the stock price of CarMax, Inc. (KMX), a used vehicle retailer, dropped by -24.6% per share. The American company’s latest quarterly performance results disappointed Wall Street, especially from the perspective of earnings per share (EPS). The current landscape of high inflation, higher interest rates (making for …

What Caught Our Attention in the Investment World? – Week of July 5-8, 2022

By Kuldip K. Ambastha GameStop Corporation (GME), a video game retailer, had an up-and-down trading week for its stock with three negative daily returns and one positive daily return. (Monday, July 4, 2022 was an American holiday – Independence Day / Fourth of July – and thus not a trading day.) (See past coverage if …

What Caught Our Attention in the Investment World? – Week of February 1-5, 2021

By Kuldip K. Ambastha During this past trading week, retail investors focused on the iShares Silver Trust ETF (SLV). The silver market is huge in market size, highly liquid, and worldwide (trading can happen for 23 hours of any given trading day). During the last trading week (What Caught Our Attention in the Investment World? …

What Caught Our Attention in the Investment World? – Week of January 25-29, 2021

By Kuldip K. Ambastha GameStop Corporation (GME), a video game retailer, caught everyone’s attention in this past trading week. Retail investors were bullish about the stock, while institutional investors were bearish about the stock. Like many companies, GameStop has struggled due to the coronavirus pandemic, which led several institutional investors to short the stock. Retail …

What Caught Our Attention in the Investment World? – Week of September 9-13, 2019

By Kuldip K. Ambastha and Anil K. Ambastha Acadia Pharmaceuticals Inc. (ACAD) is a biopharmaceutical company which has Nuplazid (aka: pimavanserin) in its product pipeline. Nuplazid has been used by individuals suffering from Parkinson’s disease-linked psychosis. Acadia has now analyzed Nuplazid in relation to individuals suffering from dementia-related psychosis. Currently, no approved drugs exist in …